Note 5 - Cash, Cash Equivalents and Investments
|9 Months Ended|
Sep. 30, 2022
|Notes to Financial Statements|
|Cash, Cash Equivalents, and Marketable Securities [Text Block]||
5. Cash, cash equivalents and investments
As of September 30, 2022, cash, cash equivalents and investments comprised funds in depository, money market accounts, U.S. treasury securities, asset-backed securities and corporate bonds. As of December 31, 2021, cash equivalents were comprised of only money market accounts. The following table presents the cash equivalents and investments carried at fair value in accordance with the hierarchy defined in Note 2 at September 30, 2022 and December 31, 2021.
Cash equivalents and marketable securities have been initially valued at the transaction price and subsequently valued, at the end of each reporting period, utilizing third party pricing services or other market observable data. The pricing services utilize industry standard valuation models, including both income and market-based approaches and observable market inputs to determine value. The Company validates the prices provided by its third-party pricing services by reviewing their pricing methods and obtaining market values from other pricing sources, as needed. After completing its validation procedures, the Company did not adjust any fair value measurements provided by the pricing services as of September 30, 2022.
Investments at September 30, 2022 consist of the following (in thousands):
The Company recorded realized gains from the maturity of available-for-sale securities of $0.2 million and $0.3 million during the three and nine months ended September 30, 2022, respectively, and recorded no realized gains or losses from the maturity of available-for-sale securities during the three and nine months ended September 30, 2021.
As of September 30, 2022, there were no investments with a fair value that was significantly lower than the amortized cost basis or any investments that had been in an unrealized loss position for a significant period.
The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef